✦ LIBER ✦

Resistance to imatinib (Glivec): update on clinical mechanisms

✍ Scribed by Ellen Weisberg; James D. Griffin

Book ID: 117764522
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 103 KB
Volume: 6
Category: Article
ISSN: 1368-7646
DOI: 10.1016/s1368-7646(03)00062-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Resistance to imatinib in chronic myelog

Resistance to imatinib in chronic myelogenous leukemia: Mechanisms and clinical implications

✍ Paul La Rosée; Andreas Hochhaus 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 703 KB

Novel agents to override imatinib resist

Novel agents to override imatinib resistance mechanisms

✍ Asumi Yokota; Shinya Kimura 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB

## Abstract Chronic myelogenous leukemia (CML) is a disorder of hematopoietic stem cells that results from the Philadelphia chromosome (Ph) created through translocation of human chromosomes 9 and 22. The resulting Bcr‐Abl fusion protein has constitutively high tyrosine kinase activity that causes

Cytogenetic and molecular mechanisms of

Cytogenetic and molecular mechanisms of resistance to imatinib

✍ Andreas Hochhaus 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 287 KB

Molecular and chromosomal mechanisms of

Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy

✍ Hochhaus, A; Kreil, S; Corbin, A S; La Rosée, P; Müller, M C; Lahaye, T; Hanfste 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 177 KB

Mechanisms of resistance to imatinib and

Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor

✍ Wei-Lien Wang; Anthony Conley; David Reynoso; Laura Nolden; Alexander J. Lazar; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 384 KB

Part I: Mechanisms of resistance to imat

Part I: Mechanisms of resistance to imatinib in chronic myeloid leukaemia

✍ Jane F Apperley 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 421 KB